Welcome, GuestSign InSign Up
Position - / - - Profile

Shanghai Jinhong Chemical Co., Ltd

Business Type
Main MarketsAmerica, North Amercia, Asia, Europe, Middle East
Product/ServiceGlutaraldehyde, Acrolein, Emamectin benzoate, EVE,etc
Business Owner

Company Introduction

Shanghai Jinhong Chemical Co., Ltd is a comprehensive chemical enterprise specialized in chemical manufacturing and logistics. With 3 manufacturing sites in different provinces in China, the company has powerful strength to supply high quality products with most competitive service.

  Jinhong Chemical insists on management philosophy of "technological innovation, industry extension", and it is the leading manufacturer of vinyl ether and glutaraldehyde in China. In 1999, the company developed acrolein products, which promoted the transformation from picoline technology into acrolein technology in producing imidocloprid pesticide, played an important role in winning international competition for imidacloprid, and made the company become the outstanding raw material supplier for imidacloprid.

  Industry extension is essential to offering better services to clients. jinhong has established complete industry chain of acrolein and vinyl ether. Our capacity of several products are: acrolein 13000t/a, glutaraldehyde 8000t/a, vinyl ethers 5000t/a, Emamectin benzoate 400t/a. the output of four leading products ranks the top in China. Shandong factory has established ligustral production line with output of 1500t/a.

  We would like to cooperate with friends from all of the world. The company strives for sustainable developed through technological innovation, closer cooperation, and industry extension.

Contact Information

Contact PersonHelen Lu
Telephone+86 13916013238
Fax Number
Post Code
Address1019D, No.999 Wangqiao Road, Pudong district, Shanghai, China
No advertising and no spamming please
Your Name
Your Rating
Shanghai Jinhong Chemical Co., Ltd no reviews currently
No reviews currently, you may post the first one.
About Us - Contact Us - Privacy Policy - Daily Updates - Report Abuse